Cresset Asset Management LLC Boosts Holdings in Humana Inc. $HUM

Cresset Asset Management LLC raised its position in Humana Inc. (NYSE:HUM) by 1,736.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 43,513 shares of the insurance provider’s stock after acquiring an additional 41,144 shares during the period. Cresset Asset Management LLC’s holdings in Humana were worth $11,359,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also made changes to their positions in HUM. Illinois Municipal Retirement Fund increased its holdings in shares of Humana by 9.6% during the third quarter. Illinois Municipal Retirement Fund now owns 49,658 shares of the insurance provider’s stock valued at $12,920,000 after acquiring an additional 4,351 shares in the last quarter. Bank of New York Mellon Corp grew its position in Humana by 161.5% during the 3rd quarter. Bank of New York Mellon Corp now owns 1,717,767 shares of the insurance provider’s stock worth $446,911,000 after purchasing an additional 1,060,767 shares during the last quarter. National Pension Service grew its position in Humana by 2.8% during the 3rd quarter. National Pension Service now owns 189,601 shares of the insurance provider’s stock worth $49,328,000 after purchasing an additional 5,150 shares during the last quarter. Tejara Capital Ltd acquired a new position in Humana during the 3rd quarter valued at approximately $1,873,000. Finally, AMG National Trust Bank raised its holdings in shares of Humana by 106.5% in the third quarter. AMG National Trust Bank now owns 16,953 shares of the insurance provider’s stock worth $4,411,000 after buying an additional 8,744 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. Raymond James Financial cut their target price on Humana from $340.00 to $230.00 and set an “outperform” rating on the stock in a research report on Friday, February 13th. Barclays dropped their price target on Humana from $245.00 to $176.00 and set an “equal weight” rating on the stock in a research note on Tuesday, February 24th. Evercore reduced their price objective on Humana from $260.00 to $180.00 in a research note on Thursday, February 12th. UBS Group reiterated a “neutral” rating on shares of Humana in a research report on Wednesday, February 25th. Finally, The Goldman Sachs Group reduced their price target on shares of Humana from $215.00 to $158.00 and set a “sell” rating for the company in a research report on Friday, February 13th. Seven investment analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and four have given a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $225.48.

Insider Activity at Humana

In other Humana news, insider Sanjay K. Shetty purchased 810 shares of the business’s stock in a transaction that occurred on Monday, February 23rd. The stock was purchased at an average price of $185.21 per share, for a total transaction of $150,020.10. Following the purchase, the insider directly owned 11,657 shares in the company, valued at approximately $2,158,992.97. This trade represents a 7.47% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.37% of the stock is owned by company insiders.

Humana Stock Down 1.4%

Shares of HUM stock opened at $180.50 on Friday. Humana Inc. has a twelve month low of $169.61 and a twelve month high of $315.35. The stock has a market cap of $21.77 billion, a P/E ratio of 18.38, a P/E/G ratio of 1.97 and a beta of 0.44. The stock has a 50 day moving average of $223.34 and a 200 day moving average of $253.27. The company has a current ratio of 2.00, a quick ratio of 2.00 and a debt-to-equity ratio of 0.70.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, February 11th. The insurance provider reported ($3.96) EPS for the quarter, topping analysts’ consensus estimates of ($4.01) by $0.05. The business had revenue of $32.64 billion for the quarter, compared to analysts’ expectations of $32.08 billion. Humana had a net margin of 0.92% and a return on equity of 11.43%. The business’s revenue was up 11.3% on a year-over-year basis. During the same quarter last year, the company earned ($2.16) EPS. Humana has set its FY 2026 guidance at 9.000-9.000 EPS. As a group, sell-side analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be paid a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a dividend yield of 2.0%. The ex-dividend date of this dividend is Friday, March 27th. Humana’s dividend payout ratio is presently 36.05%.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.